HomeCompareARZTY vs MRK

ARZTY vs MRK: Dividend Comparison 2026

ARZTY yields 26.70% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARZTY wins by $52.4K in total portfolio value
10 years
ARZTY
ARZTY
● Live price
26.70%
Share price
$7.49
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$109.2K
Annual income
$13,054.20
Full ARZTY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ARZTY vs MRK

📍 ARZTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARZTYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARZTY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARZTY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARZTY
Annual income on $10K today (after 15% tax)
$2,269.69/yr
After 10yr DRIP, annual income (after tax)
$11,096.07/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ARZTY beats the other by $2,767.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARZTY + MRK for your $10,000?

ARZTY: 50%MRK: 50%
100% MRK50/50100% ARZTY
Portfolio after 10yr
$83.0K
Annual income
$11,426.17/yr
Blended yield
13.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ARZTY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.7
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARZTY buys
0
MRK buys
0
No recent congressional trades found for ARZTY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARZTYMRK
Forward yield26.70%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$109.2K$56.8K
Annual income after 10y$13,054.20$9,798.13
Total dividends collected$71.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: ARZTY vs MRK ($10,000, DRIP)

YearARZTY PortfolioARZTY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,370$2,670.23$11,206$366.19+$2.2KARZTY
2$17,643$3,336.59$12,650$502.35+$5.0KARZTY
3$22,993$4,114.78$14,407$694.19+$8.6KARZTY
4$29,614$5,011.68$16,585$967.82+$13.0KARZTY
5$37,719$6,032.61$19,342$1,363.89+$18.4KARZTY
6$47,541$7,181.12$22,913$1,947.19+$24.6KARZTY
7$59,327$8,458.84$27,662$2,823.89+$31.7KARZTY
8$73,346$9,865.45$34,159$4,173.35+$39.2KARZTY
9$89,879$11,398.64$43,337$6,308.80+$46.5KARZTY
10$109,224$13,054.20$56,776$9,798.13+$52.4KARZTY

ARZTY vs MRK: Complete Analysis 2026

ARZTYStock

ARYZTA AG provides frozen B2B baking solutions in Europe, Asia, Australia, and New Zealand. It offers pastries, cookies, donuts, muffins, buns, bread rolls and artisan loaves, sweet baked and morning goods, and savory and other products. The company also provides asset management services; and distributes food products. It serves large retail, convenience, and independent retailers, as well as quick service restaurants and other foodservice customers. In addition, it sells product under the Hiestaud, Mette Munk, Pre Pain, Cuisine de France, Coup de Pates, La Brea, Oits Spunkmeyer, and Fornetti brands. The company has 26 bakeries in 27 countries. ARYZTA AG was founded in 1897 and is based in Schlieren, Switzerland.

Full ARZTY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ARZTY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARZTY vs SCHDARZTY vs JEPIARZTY vs OARZTY vs KOARZTY vs MAINARZTY vs JNJARZTY vs ABBVARZTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.